EW
Edwards Lifesciences Corp
88.10$
+1.4%
vs. previous close
Closing price · As of: Sep 29, 2026
Statements
Income Statement
All figures as a percentage of revenue in the same period.
Tick rows to compare them in a chart (up to 4)
| Line item | 2014 | 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | |
| 27.2% | 27.4% | 27.2% | 25.7% | 24.8% | 26.6% | 25.1% | 23.4% | 21.7% | 23.0% | 20.5% | 21.9% | |
| 72.8% | 72.6% | 72.8% | 74.3% | 75.2% | 73.4% | 74.9% | 76.6% | 78.3% | 77.0% | 79.5% | 78.1% | |
| 14.9% | 15.4% | 14.9% | 16.1% | 16.7% | 17.3% | 17.3% | 17.3% | 17.6% | 17.8% | 19.4% | 17.8% | |
| 36.9% | 34.1% | 30.5% | 28.7% | 29.2% | 28.6% | 28.0% | 28.6% | 29.1% | 29.2% | 32.9% | 34.4% | |
| 51.9% | 49.5% | 45.3% | 44.9% | 45.9% | 45.9% | 45.4% | 45.8% | 46.7% | 48.2% | 54.1% | 51.2% | |
| 21.0% | 23.1% | 27.5% | 29.4% | 29.3% | 27.6% | 29.5% | 30.8% | 31.6% | 25.5% | 25.3% | 27.0% | |
| 0.9% | 0.7% | 0.6% | 0.7% | 0.9% | 0.6% | 0.5% | 0.5% | 0.5% | 0.3% | 0.4% | 0.3% | |
| 49.2% | 25.0% | 24.9% | 30.1% | 20.5% | 26.8% | 20.9% | 32.5% | 32.8% | 26.6% | 28.5% | 21.0% | |
| 14.3% | 5.1% | 5.7% | 13.1% | 1.1% | 2.8% | 2.1% | 3.8% | 4.6% | 3.3% | 2.8% | 3.6% | |
| 34.9% | 19.8% | 19.2% | 18.1% | 19.4% | 24.1% | 18.8% | 28.7% | 28.3% | 23.4% | 76.7% | 17.7% | |
| 53.1% | 28.3% | 27.9% | 33.2% | 23.4% | 30.1% | 24.5% | 36.1% | 36.4% | 25.5% | 31.7% | 23.6% |
Data as of: September 29, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)
Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.